Kumada T - Search Results

1

Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma.

Camera S, Rimini M, Rossari F, Tada T, Suda G, Shimose S, Kudo M, Yoo C, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Bergamo F, Salani F, Marseglia M, Amadeo E, Vitiello F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Iavarone M, Cabibbo G, Montes M, Foschi FG, Vivaldi C, Lonardi S, Sho T, Niizeki T, Nishida N, Steup C, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Hiraoka A, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Persano M, Foti S, Piscaglia F, Scartozzi M, Cascinu S, Casadei-Gardini A. Camera S, et al. Among authors: kumada t. Target Oncol. 2024 Jan;19(1):29-39. doi: 10.1007/s11523-023-01029-6. Epub 2024 Jan 22. Target Oncol. 2024. PMID: 38252195

2

Incidence of hepatocellular carcinoma in chronic hepatitis C after interferon therapy.

Hayashi K, Kumada T, Nakano S, Takeda I, Kiriyama S, Sone Y, Toyoda H, Shimizu H, Honda T. Hayashi K, et al. Among authors: kumada t. Hepatogastroenterology. 2002 Mar-Apr;49(44):508-12. Hepatogastroenterology. 2002. PMID: 11995484

3

Prospective study of a high-intensity interferon-alpha regimen for chronic hepatitis C virus genotype 1b infection.

Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Kiriyama S, Tanikawa M, Sone Y, Hisanaga Y, Hayashi K. Toyoda H, et al. Among authors: kumada t. Hepatogastroenterology. 2002 Nov-Dec;49(48):1619-24. Hepatogastroenterology. 2002. PMID: 12397749

4

Characteristics and prognosis of hepatocellular carcinoma detected in sustained responders to interferon therapy for chronic hepatitis C.

Toyoda H, Kumada T, Hayashi K, Honda T, Morita K, Nishimura D, Imada K, Imoto M, Horiguchi Y, Nakano H, Nakano I, Fukuda Y; Yon-Ken HCV-HCC Follow-up Study Group. Toyoda H, et al. Among authors: kumada t. Cancer Detect Prev. 2003;27(6):498-502. doi: 10.1016/j.cdp.2003.09.007. Cancer Detect Prev. 2003. PMID: 14642559

5

Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan.

Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Hayashi K, Honda T, Kitabatake S, Kuzuya T, Nonogaki K, Kasugai T, Shimizu J. Toyoda H, et al. Among authors: kumada t. Cancer. 2004 Jun 1;100(11):2415-21. doi: 10.1002/cncr.20289. Cancer. 2004. PMID: 15160346 Free article.

6

Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.

Tada T, Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kitabatake S, Kuzuya T, Nonogaki K, Shimizu J, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J, Satomura S. Tada T, et al. Among authors: kumada t. Liver Int. 2005 Aug;25(4):848-53. doi: 10.1111/j.1478-3231.2005.01111.x. Liver Int. 2005. PMID: 15998436

7

Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan.

Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J. Toyoda H, et al. Among authors: kumada t. Am J Gastroenterol. 2005 Aug;100(8):1764-71. doi: 10.1111/j.1572-0241.2005.41943.x. Am J Gastroenterol. 2005. PMID: 16086713

8

Attenuated phosphorylation of heat shock protein 27 correlates with tumor progression in patients with hepatocellular carcinoma.

Yasuda E, Kumada T, Takai S, Ishisaki A, Noda T, Matsushima-Nishiwaki R, Yoshimi N, Kato K, Toyoda H, Kaneoka Y, Yamaguchi A, Kozawa O. Yasuda E, et al. Among authors: kumada t. Biochem Biophys Res Commun. 2005 Nov 11;337(1):337-42. doi: 10.1016/j.bbrc.2005.08.273. Biochem Biophys Res Commun. 2005. PMID: 16199221

9

Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma.

Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J. Toyoda H, et al. Among authors: kumada t. Clin Gastroenterol Hepatol. 2006 Jan;4(1):111-7. doi: 10.1016/s1542-3565(05)00855-4. Clin Gastroenterol Hepatol. 2006. PMID: 16431313

10

'Yes, now you are free from chronic HCV infection, but . . .'.

Toyoda H, Kumada T. Toyoda H, et al. Among authors: kumada t. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):9-10. doi: 10.1111/j.1440-1746.2005.04207.x. J Gastroenterol Hepatol. 2006. PMID: 16706803 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

838 results

Search Page

Filters